Geographic disparities in thyroid cancer staging at presentation: Insights from an Australian context

Zihao M. Yang,Chai W. Tong,Nazim Bhimani,Christine J. O’Neill,Christine S. L. Lai,Jonathan W. Serpell,Anthony R. Glover
DOI: https://doi.org/10.1002/wjs.12211
IF: 3.282
2024-05-12
World Journal of Surgery
Abstract:Summary Background Thyroid cancer diagnoses have increased over recent decades at a rate much higher than that of any other cancer in Australia. Rural patients are known to have reduced access to healthcare and may have different thyroid cancer presentation rates. This study examined the relationship between thyroid cancer diagnosis and patient rurality. Methods Data from the Australia and New Zealand Thyroid Cancer Registry from 2017 to 2022 were analyzed, stratifying patient postcodes into rurality groups using the Australian Statistical Geography Standard. The American Thyroid Association (ATA) guidelines were used to stratify risk categories and management to compare treatment adequacy between the groups. Statistical analysis assessed demographic, clinical, and management differences. Results Among 1766 patients, 70.6% were metropolitan (metro) and 29.4% were non‐metropolitan (non‐metro). Non‐metro patients were older at diagnosis (median 56 vs. 50 years, p
surgery
What problem does this paper attempt to address?